지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2004.6
- 수록면
- 119 - 126 (8page)
이용수
초록· 키워드
오류제보하기
For the purpose of developing new anti-HIV agents from natural sources, the extracts of Solanum nigrum L. were tested for their inhibitory effects on HIV-1 replication and its essential enzymes as the reverse transcriptase (RT), protease and α-glucosidase.
In the assay of HIV-1-infected human T-cell line, water extracts inhibited the HIV- 1 -induced cytopathic effects with IC (inhibitory concentration) of 100 ug/ml. Moreover water extracts (100ug/ml) of aerial parts showed strong activity of 32.6% on anti-HIV-1 PR using the activity of the enzyme to cleave an oligopeptide. In the HIV-1 reverse transcriptase inhibition assay, aqueous extract a inhibited 17.4%, but no glucosidase inhibitory activities.
We found out this result, for these samples it is possible that the inhibition of the viral replication in vitro is due to the inhibition at least one of PR and RT. It would be of great interest to identify the compounds which are responsible for this inhibition, since all therapeutically useful agent up to date are PR, RT and α-glucosidase inhibitors.
In the assay of HIV-1-infected human T-cell line, water extracts inhibited the HIV- 1 -induced cytopathic effects with IC (inhibitory concentration) of 100 ug/ml. Moreover water extracts (100ug/ml) of aerial parts showed strong activity of 32.6% on anti-HIV-1 PR using the activity of the enzyme to cleave an oligopeptide. In the HIV-1 reverse transcriptase inhibition assay, aqueous extract a inhibited 17.4%, but no glucosidase inhibitory activities.
We found out this result, for these samples it is possible that the inhibition of the viral replication in vitro is due to the inhibition at least one of PR and RT. It would be of great interest to identify the compounds which are responsible for this inhibition, since all therapeutically useful agent up to date are PR, RT and α-glucosidase inhibitors.
목차
Abstract
1. 서론
2. 재료 및 방법
3. 결과 및 고찰
참고문헌
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
다래나무 추출물의 HIV-1 효소억제활성과 구조활성상관(QSAR)예측
대한본초학회지(본초분과학회지)
2006 .01
-
구조활성상관(QSAR)에 의한 피마엽(？麻葉) 추출물의 HIV-1 효소억제활성인자 예측
대한한방내과학회지
2006 .01
-
HIV 감염자의 삶에 관한 연구
Women's Health Nursing
2005 .01
-
Inhibition of HIV-1 Replication by the Water-soluble Extract Mixture of Ricini Semen and Coptidis Rhizoma
The journal of applied pharmacology : the official journal of the Korean Society of Applied Pharmacology
1995 .01
-
Current Status of the Estimation on the Number of People Who Living with HIV and the Rate of Undiagnosed Cases
JOURNAL OF BACTERIOLOGY AND VIROLOGY
2020 .09
-
국내 한국인의 Human Immunodeficiency Virus ( HIV ) 감염에 관한 혈청병독학적 연구
JOURNAL OF BACTERIOLOGY AND VIROLOGY
1988 .12
-
핵산유도체들의 항 Human Immunodeficiency Virus in vitro 약효평가와 작용기전연구
JOURNAL OF BACTERIOLOGY AND VIROLOGY
1997 .06
-
오라퀵 테스트를 이용한 HIV감염의 신속 진단
Infection and Chemotherapy
2009 .01
-
HIV 다양성 문제와 해결 방법
에이즈
2000 .01
-
동아시아에서의 HIV/AIDS 역학
Infection and Chemotherapy
2007 .01
-
Development and Assessment of New RT-qPCR Assay for Detection of HIV-1 Subtypes
대한의생명과학회지
2016 .09
-
HIV병 사망자 중 결핵 사망 분율과 관련 요인
농촌의학·지역보건
2015 .06
-
사람면역결핍바이러스 감염 환자의 폐동맥 고혈압 발생빈도 및 임상양상
대한내과학회지
2011 .01
-
HIV 감염 예방의 최신 지견
대한내과학회지
2016 .01
-
치료 경험이 없는 HIV 감염자에서의 항바이러스제 일차 내성 분석: 한국HIV/AIDS 코호트 연구
Infection and Chemotherapy
2009 .01
-
HIV-Specific Cellular Immune Responses Are Stimulated by Structured Treatment Interruption in Chronically HIV-1 Infected Koreans
Yonsei Medical Journal
2006 .01
-
Implementing Expanded Rapid Human Immunodeficiency Virus Testing in Public Health Centers in Seoul, 2015
Infection and Chemotherapy
2018 .01
-
Human Immunodeficiency Virus (HIV) and Hepatitis Virus Coinfection among HIV-Infected Korean Patients: The Korea HIV/AIDS Cohort Study
Infection and Chemotherapy
2017 .01
-
HIV 감염의 정신의학적 이해와 치료적 고려점
생물치료정신의학
2020 .10
-
노인에서 사람면역결핍바이러스 감염증의 특성과 치료
대한내과학회지
2010 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2009-519-015404294